1 Min Read
Dec 2 (Reuters) - Sanofi Genzyme
* Sanofi genzyme says government of nova scotia has added lemtrada (alemtuzumab) to its pharmacare program Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.